Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sulfur-containing therapeutics in the treatment of Alzheimer's disease. | Med Chem Res | 2021 | 33613018 | PubTator, text mining | PubMed |
| MiR-200a with CDC7 as a direct target declines cell viability and promotes cell apoptosis in Wilm's tumor via Wnt/β-catenin signaling pathway. | Mol Cell Biochem | 2021 | 33599894 | PubTator, text mining | PubMed |
| A new horizon for the old antibacterial drug clofoctol. | Drug Discov Today | 2021 | 33581321 | PubTator, text mining | PubMed |
| FAN1, a DNA Repair Nuclease, as a Modifier of Repeat Expansion Disorders. | J Huntingtons Dis | 2021 | 33579867 | PubTator, text mining | PubMed |
| Metformin Reduces Histone H3K4me3 at the Promoter Regions of Positive Cell Cycle Regulatory Genes in Lung Cancer Cells. | Cancers (Basel) | 2021 | 33578894 | PubTator, text mining | PubMed |
| Human DDK rescues stalled forks and counteracts checkpoint inhibition at unfired origins to complete DNA replication. | Mol Cell | 2021 | 33545059 | PubTator, text mining | PubMed |
| The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers. | Sci Rep | 2021 | 33542435 | PubTator, text mining | PubMed |
| Use of pembrolizumab in MSI-high uterine leiomyosarcoma; a case report and review of the literature. | Gynecol Oncol Rep | 2021 | 33537390 | PubTator, text mining | PubMed |
| SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors. | Proc Natl Acad Sci U S A | 2021 | 33536335 | PubTator, text mining | PubMed |
| Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells. | J Clin Med | 2021 | 33535527 | PubTator, text mining | PubMed |
| Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. | Pharmaceutics | 2021 | 33525757 | PubTator, text mining | PubMed |
| Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. | Arch Toxicol | 2021 | 33512557 | PubTator, text mining | PubMed |
| The Jekyll and Hyde of Cellular Senescence in Cancer. | Cells | 2021 | 33494247 | PubTator, text mining | PubMed |
| Three novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network. | Cancer Cell Int | 2021 | 33482819 | PubTator, text mining | PubMed |
| Targeting pan-essential genes in cancer: Challenges and opportunities. | Cancer Cell | 2021 | 33450197 | PubTator, text mining | PubMed |
| Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13. | Blood Cancer J | 2021 | 33441535 | PubTator, text mining | PubMed |
| CARM1 regulates replication fork speed and stress response by stimulating PARP1. | Mol Cell | 2021 | 33412112 | PubTator, text mining | PubMed |
| Dual Kinase Targeting in Leukemia. | Cancers (Basel) | 2021 | 33401428 | PubTator, text mining | PubMed |
| MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. | NPJ Breast Cancer | 2021 | 33398005 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=26